Turkiye Klinikleri Journal of Medical Ethics-Law and History

.: RESEARCH
Antidepresan Kullanım Bozukluğu Sorununa Karşı Bir Normatif Çözüm Algoritması
A Normative Algorithm of Solution for the Problem of Antidepressant Use Disorder
M. Kemal TEMELa
aİstanbul Üniversitesi İstanbul Tıp Fakültesi, Tıp Tarihi ve Etik ABD, İstanbul, TÜRKİYE
Turkiye Klinikleri J Med Ethics. 2020;28(3):421-44
doi: 10.5336/mdethic.2020-76420
Article Language: TR
Full Text
ÖZET
 'Antidepresanların bilinçsizce, gereksizce, kontrolsüzce ve/veya endikasyon haricinde kullan(dır)ılışı' olarak tanımlanabilecek olan 'antidepresan kullanım bozukluğu (AKB)', bugüne dek gerek genel medyada, gerek literatürde ruh sağlığı profesyonellerince, gerekse resmî teftiş ve tespitlerde çok kez dile getirilmiş, dikkat çekilmiş olan bir meseledir. Antidepresif ilaç kullanım oranlarında kaydedilen ve de ruhsal hastalık prevalanslarındaki ve hasta popülasyonlarındaki artışlar ile açıklanamaz görünen yükselişe dair ampirik veriler, pek çok rapor ve çalışmada ortaya konmuştur. AKB'nin ortaya çıkışı için çeşitli neden ve mekanizmalar tarif edilebilirse de, sağlık çalışanları, bilhassa ruh sağlığı çalışanları, her tür AKB karşısında doğrudan veyahut dolaylı olarak sorumludurlar. Zira mesleklerinin etik yükümlülük ve icapları doğrultusunda, kişileri AKB'den korumak ve kurtarmak için hem yapabilecekleri hem de yapmaları gerekenler vardır. Bu çalışmada, yaygın varlığı daha önceki araştırmalarda ampirik, istatistik vd. verilerle ortaya konmuş olan AKB sorununa karşı, Tom. L. Beauchamp ve James F. Childress tarafından geliştirilmiş olan biyomedikal etik prensiplerinden yine Beauchamp ve Childress'a has normatif metodoloji (ayrıntılandırma) kullanılarak üretilen bir dizi etik önermede bulunulmuştur. Zira benimsenen etik prensipler tababetin nasıl icra edileceğini, tababetin nasıl icra edildiği ise ortaya çıkacak iyi ya da (AKB gibi) kötü pratik sonuçları belirler.

Anahtar Kelimeler: Antidepresan; antidepresan kullanım bozukluğu; bağımlılık; etik; tıp etiği; meslek etiği; kullanım bozukluğu
ABSTRACT
 Antidepressant use disorder (AUD) as the uninformed, undue, uncontrolled and/or off-label use of antidepressants is an issue that has been frequently reported in the literature and mass media by diverse observers, including mental health-care professionals and official regulatory bodies. There have been many studies presenting sets of empirical data showing the increased rates of antidepressive drug use that appear to be unexplainable by a parallel increase in mental illness rates and patient populations. Although various mechanisms and causes could be suggested for AUD, health-care professionals, particularly mental health-care professionals, may be held directly or indirectly liable for all observed patterns of AUD, as they have both the potential and the duty to protect and rescue individuals from AUD, in accordance with the ethical obligations and requirements of their profession. In an effort against the problem of AUD, the prevalent presence of which has previously been shown based on empirical, statistical and other data, this study formulates a number of ethical propositions as derived from the principles of biomedical ethics developed by Tom. L. Beauchamp and James F. Childress, by using the normative method of specification, also articulated by Beauchamp and Childress. The ethical principles adopted outline how doctoring ought to be performed, and how doctoring is performed determines the positive or negative outcomes, such as AUD.

Keywords: Antidepressant; antidepressant use disorder; dependence; ethics; medical ethics; professional ethics; use disorder
REFERENCES:
  1. Temel MK. ["Antidepressant use disorder" as a result of modern psychosocioclinical factors: a medical-ethically problematic phenomenon]. Anatol Clin. 2019;24(3):206-16.
  2. WHO. Depression and Other Common Mental Disorders: Global Health Estimates. Cenevre: WHO Document Production Services; 2017. https://www.who.int/mental_health/management/depression/prevalence_global_health_estimates/en/
  3. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8):848-56. [Crossref]  [PubMed] 
  4. Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61(1):10-3. [PubMed] 
  5. Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2011-2014. NCHS Data Brief. 2017(283):1-8. [PubMed] 
  6. Prescribing and Medicines Team Health and Social Care Information Centre. Prescriptions Dispensed in the Community England 2005-2015. https://files.digital.nhs.uk/publicationimport/pub20xxx/pub20664/pres-disp-com-eng-2005-15-rep.pdf
  7. Aydın N, Çetin M, Kurt E, Savaş H, Açıkel C, Kılıç S, et al. [A report by Turkish association for psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications]. Bulletin of Clinical Psychopharmacology. 2013;23(4):390-402. [Crossref] 
  8. Psikofarmakoloji Derneği. Türkiye'de psikotrop ilaç tüketimi. 2013. Erişim tarihi: 15 Ekim 2016. www.turkpsikiyatri.org/blog/2013/05/01/turkiyede-psikotrop-ilac-tuketimi
  9. Karabağlı H. Türkiye'nin yarısı antidepresan mı kullanıyor? T24. Yayın tarihi: 20 Kasım 2012. Erişim tarihi: 10 Ağustos 2017. http://t24.com.tr/haber/turkiyenin-yarisi-anti-depresan-mi-kullaniyor,217863
  10. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Başkanlığı. Kocaeli Milletvekili Lütfü Türkkan tarafından verilen "Antidepresan ilaçların kullanımındaki artışa ilişkin" 7/13159 esas nolu yazılı soru önergesinin cevabıdır. Erişim tarihi: 1 Ağustos 2017. www2.tbmm.gov.tr/d24/7/7-13159sgc.pdf
  11. Temel MK. Modern psikososyoklinik etmenlerin eseri "antidepresan kullanım bozukluğu" ve tıp etiği prensiplerince değerlendirilişi [yayımlanmamış doktora tezi]. İstanbul: İ.Ü. İstanbul Tıp Fakültesi, Sağlık Bilimleri Enstitüsü, Tıp Tarihi ve Etik Anabilim Dalı; 2018.
  12. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 7th ed. Oxford: Oxford University Press; 2013. p.459.
  13. Beauchamp TL, Childress JF. Ahlaki normlar. Özerkliğe saygı. Zararsızlık. Yararlılık. Adalet. In: Biyomedikal Etik Prensipleri. 7th ed. Temel MK, çevirmen. İstanbul: BETİM; 2017. p. 21, 26-36, 229-30, 154, 155, 161, 163, 176, 189, 415, 314-5.
  14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd ed. Washington, ABD: American Psychiatric Publishing; 1980. p.512.
  15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders; DSM-IV. 4th ed. Washington, DC/ABD: American Psychiatric Association; 1994. p.886.
  16. American Psychiatric Association. Major depressive disorder. In: Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 5th ed. Washington, DC/ABD: American Psychiatric Pub.; 2013. p.160-8.
  17. American Psychiatric Association. Çeviri editörü: Köroğlu E. Ruhsal Bozuklukların Tanısal ve Sayımsal Elkitabı DSM-5?. 5. Baskı. Ankara: Hekimler Yayın Birliği; 2015. p.1200.
  18. World Health Organization. WHO Expert Committee on Drug Dependence: Sixteenth Report. Cenevre: World Health Organization; 1969. https://apps.who.int/iris/bitstream/handle/10665/40710/WHO_TRS_407.pdf?sequence=1&isAllowed=y
  19. World Health Organization. WHO Expert Committee on Drug Dependence: Thirty-third Report. Cenevre: World Health Organization; 2003. https://apps.who.int/iris/bitstream/handle/10665/42655/WHO_TRS_915.pdf?sequence=1&isAllowed=y
  20. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. ICD-10 Version: 2016. Erişim tarihi: 3 Haziran 2017. https://icd.who.int/browse10/2016/en
  21. Türkiye Yeşilay Cemiyeti. Teknoloji bağımlılığı nedir? Erişim tarihi: 1 Haziran 2017. www.yesilay.org.tr/tr/bagimlilik/teknoloji-bagimliligi
  22. Türkiye Yeşilay Cemiyeti. Kumar bağımlılığı nedir? Erişim: 1 Haziran 2017. www.yesilay.org.tr/tr/bagimlilik/kumar-bagimliligi
  23. Örsel S. Depresyonda tedavi: genel ilkeler ve kullanılan antidepresan ilaçlar. Klinik Psikiyatri. 2004;7(Ek 4):17-24.
  24. Hamilton M. The clinical distinction between anxiety and depression. Br J Clin Pharmacol. 1983;15(Suppl 2):165S-9. [Crossref]  [PubMed]  [PMC] 
  25. Ilardi S. Depression: tragically misunderstood. Psychology Today. Yayın tarihi: 5 Temmuz 2009. Erişim tarihi: 15 Kasım 2017. www.psychologytoday.com/blog/the-depression-cure/200907/depression-tragically-misunderstood
  26. Parekh R. What is depression? American Psychiatric Association. Yayın tarihi: 2017. Erişim tarihi: 30 Mayıs 2017. www.psychiatry.org/patients-families/depression/what-is-depression
  27. Conrad P. The discovery of hyperkinesis: notes on the medicalization of deviant behavior. Soc Probl. 1975;23(1):12-21. [Crossref]  [PubMed] 
  28. Conrad P. Medicalization and social control. Annu Rev Sociol. 1992;18:209-32. [Crossref] 
  29. Illich I. The medicalization of life. J Med Ethics. 1975;1(2):73-7. [Crossref]  [PubMed]  [PMC] 
  30. Geçtan E. Psikodinamik Psikiyatri ve Normaldışı Davranışlar. 13. Baskı. İstanbul: Remzi Kitabevi; 1997. p.291.
  31. Frankenberger KA, Frankenberger WR, Peden BF, Hunt HL, Raschick CM, Steller EG. Effects of information on college students' perceptions of antidepressant medication. J Am Coll Health. 2004;53(1):35-40. [Crossref]  [PubMed] 
  32. Kadison R. Getting an edge - - use of stimulants and antidepressants in college. N Engl J Med. 2005;353(11):1089-91. [Crossref]  [PubMed] 
  33. Bertschy G, Luxembourger I, Bizouard P, Vandel S, Allers G, Volmat R. [Amineptin dependence. Detection of patients at risk. Report of 8 cases]. Encephale. 1990;16(5):405-9. [PubMed] 
  34. De los Cobos JCP, Jorda LL, Pelegrin C. [A case of amineptine dependence]. Encephale. 1990;16(1):41-2. [PubMed] 
  35. Durmuş N, Ozbilen G, Kasap Y, Koyuncu O, Yildirim O, Artiran G, et al. Risk management in tianeptine abuse in Turkey: a national experience. Bulletin of Clinical Psyhopharmacology. 2013;23(2):149-54. [Crossref] 
  36. Eşsizoğlu A, Yaşan A, Bülbül İ, Karabulut E, Gürgen F. Venlafaxine addiction without a history of alcohol and substance abuse: a case report. Düşünen Adam The Journal of Psychiatry and Neurological Sciences. 2012;25(4):376-8.
  37. Guillem E, Lépine JP. [La toxicomanie aux antidépresseurs existe-t-elle? À propos d'un cas de dépendance à la tianeptine]. Encephale. 2003;29(5):456-9.
  38. Haddad P. Do antidepressants have any potential to cause addiction? J Psychopharmacol. 1999;13(3):300-7. [Crossref]  [PubMed] 
  39. Kisa C, Ozen Bulbul D, Aydemir C, Goka E. Is it possible to be dependent to tianeptine, an antidepressant? A case report. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(3):776-8. [Crossref]  [PubMed] 
  40. Lapsekili N, Yavuz KF. Tianeptine abuse: a case report. Düşünen Adam The Journal of Psychiatry and Neurological Sciences. 2014;27(1):1-4.
  41. Quaglio G, Schifano F, Lugoboni F. Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse. Addiction. 2008;103(9):1572-4. [Crossref]  [PubMed] 
  42. Saatçioğlu Ö, Erim R, Çakmak D. A case of tianeptine abuse. Türk Psikiyatri Dergisi. 2006;17(1):72-5.
  43. Vadachkoria D, Gabunia L, Gambashidze K, Pkhaladze N, Kuridze N. Addictive potential of tianeptine: the threatening reality. Georgian Med News. 2009;(174):92-4. [PubMed] 
  44. Welsh CJ, Doyon S. Seizure induced by insufflation of bupropion. N Engl J Med. 2002;347(12):951. [Crossref]  [PubMed] 
  45. Boyd CJ, McCabe SE. Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy. 2008;3:22. [Crossref]  [PubMed]  [PMC] 
  46. Çeler A, Kara İH, Baltacı D, Çeler H. [Investigation of the relationship of job satisfaction and depression level among medical faculty research assistants]. Konuralp Tıp Dergisi. 2015;7(3):125-33. [Crossref] 
  47. Evans EA, Sullivan MA. Abuse and misuse of antidepressants. Subst Abuse Rehabil. 2014;5:107-20. [Crossref]  [PubMed]  [PMC] 
  48. Franke AG, Bagusat C, Dietz P, Hoffmann I, Simon P, Ulrich R, et al. Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med. 2013;11:102. [Crossref]  [PubMed]  [PMC] 
  49. Fujii K, Suzuki T, Mimura M, Uchida H. Psychological dependence on antidepressants in patients with panic disorder: a cross-sectional study. Int Clin Psychopharmacol. 2017;32(1):36-40. [Crossref]  [PubMed] 
  50. Hernandez SH, Nelson LS. Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther. 2010;88(3):307-17. [Crossref]  [PubMed] 
  51. Özsoylu S, Akyıldız B, Dursun A. [Burnout levels and affecting factors in nurses working in a university hospital]. J Pediatr Emerg Intensive Care Med. 2017;4:104-9. [Crossref] 
  52. Zullig KJ, Divin AL. The association between non-medical prescription drug use, depressive symptoms, and suicidality among college students. Addict Behav. 2012;37(8):890-9. [Crossref]  [PubMed] 
  53. Smith MD, Hong BA, Robson AM. Diagnosis of depression in patients with end-stage renal disease. Comparative analysis. Am J Med. 1985;79(2):160-6. [Crossref]  [PubMed] 
  54. Yalçın BM, Öztürk O. [The management of major depressive disorder in primary care]. TJFM&PC. 2016;10(4):250-8. [Crossref] 
  55. Baribeau D, Araki KF. Intravenous bupropion: a previously undocumented method of abuse of a commonly prescribed antidepressant agent. J Addict Med. 2013;7(3):216-7. [Crossref]  [PubMed] 
  56. Evren C. [Use of antidepressants in smoking cessation treatment: bupropion]. Bulletin of Clinical Psychopharmacology. 2001;11(3):198-211.
  57. Miller K. Off-label drug use: what you need to know. WebMD. 2009. Erişim tarihi: 2 Şubat 2018. www.webmd.com/a-to-z-guides/features/off-label-drug-use-what-you-need-to-know
  58. Temel MK. 1950'li yıllar ve antidepresif psikofarmakoterapi: prototiplerinden bugüne klinik antidepresanların tasnif ve tarihi. Turkiye Klinikleri J Med Ethics. 2019;27(2):89-102. [Crossref] 
  59. Sayın A, Yüksel N. [Pharmacological treatment of anxiety disorders]. Turkiye Klinikleri J Psychiatry-Special Topics. 2010;3(4):96-102.
  60. Schatzberg AF. New indications for antidepressants. J Clin Psychiatry. 2000;61(Suppl 11):9-17. [PubMed] 
  61. Francesconi G, Orsolini L, Papanti D, Corkery JM, Schifano F. Venlafaxine as the "baby ecstasy"? Literature overview and analysis of web-based misusers' experiences. Hum Psychopharmacol. 2015;30:255-61. [Crossref]  [PubMed] 
  62. Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005;45(2):144-52. [Crossref]  [PubMed] 
  63. Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003;37(11):1561-5. [Crossref]  [PubMed] 
  64. Schaffer L. This is why a third of antidepressants are prescribed for something else. CNN Heallth. Yayın Tarihi: 19 Aralık 2017. Erişim tarihi: 2 Şubat 2018. www.edition.cnn.com/2017/12/19/health/new-use-for-antidepressants-bowel-crohns-disease-partner/index.html
  65. Healy D. The Doctoring of Madness before Chlorpromazine. The Creation of Psychopharmacology. 1. baskı. Cambridge, MA/ABD: Harvard University Press; 2002. p.56.
  66. Noll R. The Encyclopedia of Schizophrenia and Other Psychotic Disorders. 3rd ed. New York: Facts on File; 2007. p.409.
  67. Phelps L. Psychopharmacology for pediatric neuropsychologists. Davis AS, ed. The Handbook of Pediatric Neuropsychology. 1. baskı. New York: Springer Publishing Company; 2011. p.1077-84.
  68. Wong J, Motulsky A, Eguale T, Buckeridge DL, Abrahamowicz M, Tamblyn R. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015. JAMA. 2016;315(20):2230-2. [Crossref]  [PubMed] 
  69. Chen Y, Kelton CML, Jing Y, Guo JJ, Li X, Patel NC. Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Res Social Adm Pharm. 2008;4(3):244-57. [Crossref]  [PubMed] 
  70. Kelton CML, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ. Differences in the cost of antidepressants across state Medicaid programs. J Ment Health Policy Econ. 2008;11(1):33-47. [PubMed] 
  71. Sansone RA, Sansone LA. Doctor shopping: a phenomenon of many themes. Innov Clin Neurosci. 2012;9(11-12):42-6. [PubMed] 
  72. T.C. Sağlık Bakanlığı Sağlığın Geliştirilmesi Genel Müdürlüğü. Akılcı antibiyotik kullanımı kamu spotu. Yayın tarihi: 24 Ocak 2017. Erişim tarihi: 10 Ekim 2017. https://sggm.saglik.gov.tr/TR,31905/akilci-antibiyotik-kullanimi-kamu-spotu.html

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com